Business
Result of General Meeting/PDMR Dealings
Result of General Meeting/PDMR Dealings.
About this update from Oxford Biodynamics Plc
[{"type":"text","content":"\n\nTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR IN OR INTO ANY OTHER JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION.\nUNLESS OTHERWISE INDICATED, CAPITALISED TERMS IN THIS ANNOUNCEMENT HAVE THE MEANINGS GIVEN TO THEM IN THE DEFINITIONS SECTION OF THE CIRCULAR TO SHAREHOLDERS OF THE COMPANY DATED 22 OCTOBER 2025.\n \nOxford BioDynamics PLC\n(\"OBD\" or the \"Company\" and, together with its subsidiaries, the \"Group\")\nResult of General Meeting\nDirector/PDMR Dealings\n7 November 2025 - Oxford BioDynamics PLC (AIM: OBD), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform announces that the resolutions proposed at the General Meeting of the Company, held earlier today, were duly passed.\n \nFurther to the passing of the resolutions at the General Meeting, applications have been made for 2,333,333,326 new ordinary shares of £0.001 each in the capital of the Company (\"Ordinary Shares\"), to be issued pursuant to the fundraising announced on 22 October 2025 (the \"Fundraising\"), to be admitted to trading on AIM, comprising: (i) 208,333,332 Placing Shares (the \"VCT/EIS Placing Shares\"); and (ii) 2,093,333,329 Placing Shares (the \"General Placing Shares\") and 31,666,665 Subscription Shares.\n \nIt is expected that admission of the VCT/EIS Placing Shares (\"VCT/EIS Admission\") will take place, and trading in the VCT/EIS Placing Shares will commence at 8.00 a.m. on 10 November 2025 and that admission of the General Placing Shares and the Subscription Shares (\"General Admission\") will take place, and trading in the General Placing Shares and the Subscription Shares will commence at 8.00 a.m. on 11 November 2025.\n \nFollowing VCT/EIS Admission, the Company's issued ordinary share capital and total voting rights will consist of 2,165,910,973 Ordinary Shares. Following General Admission, the Company's issued ordinary share capital and total voting rights will consist of 4,290,910,967 Ordinary Shares. These figures should be used by shareholders as the denominator for the calculation by which they ...